Evolocumab is an injectable cholesterol drug that lowers LDL by roughly 60%, far more than any pill, by blocking a protein called PCSK9. Most people end up on it because their LDL is still too high despite a statin (often plus ezetimibe) and they need a much bigger lever, or they genuinely can't tolerate statins and need strong LDL lowering without them. It's sold as Repatha, given as a self-injection every two weeks or once a month.

This is one of the few lipid drugs with hard outcome data behind it, not just a number on a lab report. In people with existing heart disease it cuts the risk of heart attacks, strokes, and the procedures that follow, and as of late 2025 it's also been shown to prevent first events in high-risk people who haven't had one yet. You won't feel anything taking it, the effect is entirely on your bloodwork and your long-term risk, and it's well tolerated. The main practical downsides are that it's an injection and it's expensive.

Deep-dive


Dosage:


Here's what you can expect:

You will not feel anything. Evolocumab has no perceptible day-to-day effect, no energy change, nothing you'd notice. The only evidence it's working is a blood test, and on that test the change is dramatic: LDL roughly 60% lower, usually landing in the 30-40 mg/dL range, showing up within the first few weeks and stable from then on.

The thing you might notice is at the injection site, mild redness, an itch, or tenderness for a day or so. It's the most common real effect and usually fades as you get used to the technique.

Everything else is invisible and long-term: a lower heart attack and stroke risk that compounds the longer you stay on it, and, if it were imaged, slow regression of arterial plaque. This is a number-mover and a risk-mover, not something you experience.


Side effects & risks: